STEAP4 and neoplasm: This implies that in addition to secreting NRG1,[20] chemokines,[21] and inflammatory factors,[22] STEAP4+ myoCAF may also secrete specific lipids to facilitate tumor cell proliferation and survival under the selective pressure of enzalutamide.